Health Minister Dr Aaron Motsoaledi has revealed that medicines frequently affected by stock disruptions include antibiotics, tuberculosis medicines, oncology products, insulin, and selected ...

Health Minister Dr Aaron Motsoaledi reveals the ongoing challenges of medicine stock disruptions in South Africa, detailing ...

Biologics have created revolutionary treatment options that have transformed the care journey for hundreds of millions of patients worldwide. In some cases, a painless injection is all that is now ...

Conclusion: Granulocyte colony-stimulating factor (G-CSF) products can be prescribed for outpatient use. We have organized whether injectable drugs classified as "granulocyte colony-stimulating factor ...

Approval covers all current IV isatuximab indications and introduces the first oncology product labeled for both OBI and manual SC administration. IRAKLIA (NCT05405166) established noninferiority of ...

Trutakna (atacicept-vymj), a first-in-class dual BAFF and APRIL inhibitor, secured FDA accelerated approval to reduce proteinuria in adults with primary IgA nephropathy, supported by data ...

The FDA has approved Tryngolza (olezarsen) to reduce triglycerides and acute pancreatitis risk in adults with severe hypertriglyceridemia (TG ≥500mg/dL).